WebMar 28, 2024 · Despite having pared its R&D expense down to de minimis amounts, CytoDyn's annualized expenses are running up above $60 million. Fortunately the biggest chunk of that is its non-cash inventory... WebApr 13, 2024 · Following the Company's 2024 Annual Meeting of Stockholders, the Board of Directors declared a quarterly dividend of 70 cents per share, payable June 9, 2024, to shareholders of record on May 31, 2024. This marks the 447th consecutive dividend paid by the Company or its affiliates since 1912.
2024-11-24 OTCQB:CYDY Press Release CytoDyn Inc
WebBoard of Directors Meeting on May 14, 2024 and Shareholders' Meeting on June 30, 2024. The Board Meeting proposal's content, pricing method, and selection of placee were inspected and it was concluded that they meet the rule stipulated by Securities and Exchange Act and related regulation. The Company has net income after tax and no WebNov 24, 2024 · Shareholders approved all four proposals up for consideration at the Annual Meeting, including: The election of six directors to serve on the Board of … how to take long screenshot in windows
CytoDyn to Hold Webcast and Live Q/A on October 26
Web23 hours ago · Reuters. MILAN - Stellantis shareholders on Thursday approved the compensation package for the car maker's top management, including for CEO Carlos Tavares, after rejecting it last year. WebOct 18, 2024 · CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that shareholders will receive proxy material beginning this week from the Company in connection with its upcoming 2024 … WebNov 24, 2024 · November 24, 2024 - 4:01 pm. Shareholders Approve All Proposals. VANCOUVER, Wash. CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced the preliminary vote results from the 2024 … ready to eat breakfast food